(Q44008809)

28 November 2017

QS-21 structure/function studies: effect of acylation on adjuvant activity (English)

1 reference

28 November 2017

Gui Liu

1

1 reference

28 November 2017

Christine Anderson

2

1 reference

28 November 2017

Heidi Scaltreto

3

1 reference

28 November 2017

Jeffrey Barbon

4

1 reference

28 November 2017

Charlotte R Kensil

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

28 November 2017

1 reference

28 November 2017

20

1 reference

28 November 2017

2808-2815

1 reference

28 November 2017

21-22

1 reference

Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

QS-21: a water-soluble triterpene glycoside adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900209-8

7 January 2021

10.1016/S0264-410X(02)00209-8

Identifiers

DOI

1 reference

28 November 2017

1 reference